Chemical Synthesis Laboratories
These facilities include three laboratories (SQ1, SQ2, SQ3) dedicated to the synthesis of novel non-radioactive molecules to be applied in the development of molecular/nanosized tools for application in nuclear imaging (PET or SPECT) or radionuclide therapy, namely for cancer theranostics.
The research activities developed in these facilities are focused on the synthesis of organic compounds, and inorganic or organometallic complexes of d- and f- transition elements. Organic compounds include biologically active molecules and bifunctional chelators, with or without biologically active fragments, to prepare the stable d- and f- transition metal complexes.
All the synthesized compounds are characterized by multinuclear NMR spectroscopy, X-ray crystallography, mass spectrometry and HPLC.
Fume cupboards with nitrogen and vacuum lines
SQ1 - Paula Cabral Campello 219946233
SQ2 - Célia Fernandes 219946226
SQ3 - João Galamba Correia 219946233